Prescription drug · ANDA
Aminocaproic acid NDC 81033-033
Aminocaproic acid 500 mg/1 · Tablet · Oral · Kesin Pharma Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 81033-033-31 | 8103300333181033003331 | 3 BLISTER PACK in 1 CARTON (81033-033-31) / 30 TABLET in 1 BLISTER PACK (81033-033-51)Marketed from Nov 2, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aminocaproic acid
- Generic name (nonproprietary)
- aminocaproic acid
- Active ingredients
- Aminocaproic acid — 500 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Kesin Pharma CorporationNDC labeler code 81033
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 212938
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Fibrinolysis (Physiologic effect)
- Identifiers
- Product ID 81033-033_5e5ebfc9-20ff-e655-e063-6294a90a6d95SPL ID 5e5ebfc9-20ff-e655-e063-6294a90a6d95SPL set ID 5e5ebfcb-c3a2-1fcf-e063-6394a90a356aUNII U6F3787206
- Pharmacologic class
- Antifibrinolytic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N481033003331followed by a unit qualifier and the quantityPackage 81033-0033-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Aminocaproic acid tablets, USP is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. Urinary fibrinolysis, usually a n…
Excerpt only. Read the full label for complete information.
About NDC 81033-033
- What is NDC 81033-033?
- 81033-033 is the product NDC for Aminocaproic acid, Aminocaproic acid 500 mg/1 tablet, listed with the FDA by Kesin Pharma Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Aminocaproic acid.
- What is the active ingredient?
- Aminocaproic acid.
- Who is the labeler?
- Kesin Pharma Corporation, NDC labeler code 81033. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Aminocaproic acid?
- 36 other product NDCs are listed under this name. See all Aminocaproic acid NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Aminocaproic acid products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Aminocaproic Acid | Aminocaproic acid 500 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | 16571-326 | 16571-0326-03 |
| Aminocaproic Acid | Aminocaproic acid 1000 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | 16571-327 | 16571-0327-03 |
| Aminocaproic Acid | Aminocaproic acid .25 g/mL | SolutionOral | Florida Pharmaceutical Products, LLC | 71921-175 | 71921-0175-08 |
| Aminocaproic Acid | Aminocaproic acid .25 g/mL | SolutionOral | Apozeal Pharmaceuticals Inc. | 83745-294 | 83745-0294-08 |
| Aminocaproic acid | Aminocaproic acid .25 g/mL | SolutionOral | Novadoz Pharmaceuticals LLC | 72205-032 | 72205-0032-7172205-0032-72 |
| Aminocaproic Acid | Aminocaproic acid .25 g/mL | SolutionOral | Vitruvias Therapeutics | 69680-114 | 69680-0114-08 |
| Aminocaproic acid | Aminocaproic acid 1000 mg/1 | TabletOral | Novadoz Pharmaceuticals LLC | 72205-286 | 72205-0286-30 |
| Aminocaproic Acid | Aminocaproic acid 500 mg/1 | TabletOral | American Health Packaging | 60687-739 | 60687-0739-25 |
| Aminocaproic Acid | Aminocaproic acid 500 mg/1 | TabletOral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-798 | 24658-0798-30 |
| Aminocaproic Acid | Aminocaproic acid 1000 mg/1 | TabletOral | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | 24658-799 | 24658-0799-30 |
Other NDCs under ANDA 212938
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aminocaproic acid | Aminocaproic acid 500 mg/1 | TabletOral | Novadoz Pharmaceuticals LLC | 72205-049 |
| Aminocaproic acid | Aminocaproic acid 1000 mg/1 | TabletOral | Novadoz Pharmaceuticals LLC | 72205-286 |